Profiel
R.
Michael Floyd was the founder of Elion Oncology, Inc., founded in 2016, and held the titles of President, Chief Executive Officer & Director at the company.
Mr. Floyd is also the founder of BioAim LLC,Exbaq LLC..
Mr. Floyd was Chief Executive Officer-North America at EvoNext Holdings SA. Mr. Floyd was Chief Operating Officer at Processa Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Floyd completed undergraduate education at Georgetown University.
Eerdere bekende functies van R. Floyd
| Bedrijven | Functie | Einde |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Operationeel Directeur | 31-08-2023 |
BioAim LLC | Oprichter | - |
Exbaq LLC | Oprichter | - |
| EVONEXT HOLDINGS SA | Corporate Officer/Principal | - |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Oprichter | - |
Opleiding van R. Floyd
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolva Holding SA
Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Health Technology |
BioAim LLC | |
Exbaq LLC |
















